Detailed ANA dynamics under adalimumab therapy show no significant correlation to PASI response and MTX cotreatment: a retrospective study of 98 psoriasis patients.

Hoffmann, J H O; Knoop, C; Enk, A H; Hadaschik, E N

Hoffmann, J H O; Knoop, C; Enk, A H; Hadaschik, E N.

Affiliation

Hoffmann JHO; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
Knoop C; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
Enk AH; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
Hadaschik EN; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.

J Eur Acad Dermatol Venereol ; 33(3): e128-e129, 2019 Mar.

Article in En | MEDLINE | ID: mdl-30394590

Subject(s)

Adalimumab/therapeutic use; Anti-Inflammatory Agents/therapeutic use; Antibodies, Antinuclear/blood; Psoriasis/drug therapy; Adult; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents/therapeutic use; Male; Methotrexate/therapeutic use; Middle Aged; Psoriasis/blood; Retrospective Studies; Severity of Illness Index

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antibodies, Antinuclear / Adalimumab / Anti-Inflammatory Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2019 Document type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google